Articles tagged with "Drugs"

Letters

Staff | September 1, 2011

Feedback from our readers

Information on new approvals and medication safety

David S. Pisetsky, MD, PhD | August 1, 2011

A stretch-limo ride with academic rheumatologists leads to reflection

Aryeh M. Abeles, MD | July 12, 2011

Why are so many brand-name drugs approved after generic versions become available?

Information on New Approvals and Medication Safety

Information on New Approvals and Medication Safety

Dimitrios T. Boumpas, MD; George Bertsias, MD | April 13, 2011

It’s time for a new strategy

Information on New Approvals and Medication Safety

Mary Desmond Pinkowish | March 18, 2011

Recent meta-analysis points to MI risks, but many questions remain

Jean-Pierre Pelletier, MD, and Johanne Martel-Pelletier, PhD | March 18, 2011

Few effective treatments for OA have been developed, and the approach to clinical trials might need modifications